MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-27-2026
AIM ImmunoTech DIO Ratio 2011-2026 | AIM
Annual DIO Ratio AIM ImmunoTech
| 2025 | 2024 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 303 | - | - | 83.1 | 314 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 314 | 83.1 | 233 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B |  USA |
 |
BeiGene, Ltd.
BGNE
|
304 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
bluebird bio
BLUE
|
125 | - | - | $ 546 M | USA |
 |
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Amphastar Pharmaceuticals
AMPH
|
166 | $ 21.38 | 0.09 % | $ 999 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - |  Russia |
 |
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M |  Canada |
 |
Akebia Therapeutics
AKBA
|
147 | $ 1.56 | 6.12 % | $ 401 M | USA |
 |
Aquestive Therapeutics
AQST
|
120 | $ 4.15 | -0.95 % | $ 444 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
185 | $ 25.09 | 4.02 % | $ 3.19 B | USA |
 |
Autolus Therapeutics plc
AUTL
|
70.7 | $ 1.48 | 0.68 % | $ 394 M | Britain |
 |
AstraZeneca PLC
AZN
|
206 | - | - | $ 96.9 B | Britain |
 |
CTI BioPharma Corp.
CTIC
|
38.1 | - | - | $ 1.2 B | USA |